Research Nester has recently announced new market demand assessment research titled “Stem Cell & Regenerative Medicine Market – Global Demand Analysis & Opportunity Outlook 2023”. The global market study provides a granular data and in-depth analysis on the current and future market situations that are crucial for the existing &new players in the market. The industry research is based on key factors like demand & supply analysis, commercial activities, research investments, pricing analysis, government initiatives & guidelines, driving forces in the market, roadblocks and segmentation based on the product viability.
The global regenerative medicines market is expected to reach USD 50.11 billion by 2021, registering a CAGR of 12.7% during the period of 2015-2021. On the back of expanded demand of bone & joint reconstructive surgeries in the nation, North America with maximum share in global regenerative dominated the market followed by Europe in 2015. Further, it is projected that by 2019 Europe may surpass the North America market in the field of stem cell and regenerative medicine. Eastern and Western Europe are projected to show expanded demand as the need for transplants through regenerative medicines will be increasing for many applications in near future. Further backed up by the increased medical tourism in the continent, Asia-Pacific countries are also expected to show up-surged demand during 2015-2021. In addition to that, Asia-Pacific becoming one of top continent in supplying regenerative medicine bone and joint products in countries like India, China, Japan and South Korea are further projected to give a boost to the stem cell market in the region.
Expanded funding from the governments organizations and collaborations with domestic players for the entry in the nation specific market would further anticipate the market of Stem Cells & Regenerative Medicine. The growth in medical researches across the globe is the major driver for this market.
In addition to that, a rapid shift and advancement in healthcare researches would further anticipate the Stem Cells & Regenerative Market worldwide. The flexible manufacturing technology employed is further projected to fuel the Regenerative Medicine Market across the globe.
US was the largest influenza vaccine market in the year 2010 followed by China. Due to presence of bacteria in the environment rises the number of infected persons in the respective nations in 2010. The rapid growth in population and acquisition of land for the infrastructural facilities would raise the congestion level across the globe which would further leads to have more casualties of influenza and this increasing numbers of casualties would fueled up the growth of Influenza vaccine across the globe.
Analysis By Segments
On the basis of product, we have studied the market on the following segments:-
Following are the leaders across the globe:-
- Advanced Cell Technology Inc.
- Cellartis AB
- Cellular Engineering Technologies Inc.
- Bio Time Inc.
- International Stem Cell Corporation
- Medtronic, Inc.
- Zimmer Holdings, Inc.
- Orthofix, Inc.
- NuVasive, Inc.
- North America (United States / U.S., Canada)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia, Poland, Rest of Eastern Europe)
- Asia-Pacific (China, India, Singapore, Japan, Australia & New Zealand & Rest of Asia)
- Rest of World
To know more on coverage, click on the link below:-
Phone : U.S. +1 646 586 9123
U.K. +44 203 608 5919